IN: Armando Anthony "Chick" Corea (born June 12, 1941) is an American jazz pianist/electric keyboardist and composer. His compositions "Spain", "500 Miles High", "La Fiesta" and "Windows", are considered jazz standards. As a member of Miles Davis's band in the late 1960s, he participated in the birth of jazz fusion. In the 1970s he formed the fusion band Return to Forever.

In the 1970s Corea started working with vibraphonist Gary Burton, with whom he recorded several duet albums for ECM, including 1972's Crystal Silence. They reunited in 2006 for a concert tour. A new record called The New Crystal Silence was issued in 2008 and won a Grammy Award in 2009. The package includes a disc of duets and another disc with the Sydney Symphony Orchestra.  Toward the end of the 1970s, Corea embarked on a series of concerts and two albums with Hancock. These concerts were presented in elegant settings with both pianists dressed formally and performing on Yamaha concert grand pianos. The two traded playing each other's compositions, as well as pieces by other composers such as Bela Bartok. In 1982, Corea performed The Meeting, a live duet with the classical pianist Friedrich Gulda.  In December 2007 Corea recorded a duet album, The Enchantment, with banjoist Bela Fleck. Fleck and Corea toured extensively for the album in 2007. Fleck was nominated in the Best Instrumental Composition category at the 49th Grammy Awards for the track "Spectacle".  In 2008 Corea collaborated with Japanese pianist Hiromi Uehara on the live album Duet (Chick Corea and Hiromi). The duo played a concert at Tokyo's Budokan arena on April 30.  In 2015 Corea reprised the duet concert series with Hancock, again sticking to a dueling-piano format, though both also had synthesizers at their station. The first concert in this series was played at the Paramount Theatre in Seattle, and featured improvised music along with iconic songs from each of the duo and standards from other composers.

What songs did they duet to?

OUT: 1972's Crystal Silence.


IN: Jonas Edward Salk (; October 28, 1914 - June 23, 1995) was an American medical researcher and virologist. He discovered and developed one of the first successful polio vaccines. Born in New York City, he attended New York University School of Medicine, later choosing to do medical research instead of becoming a practicing physician. In 1939, after earning his medical degree, Salk began an internship as a physician scientist at Mount Sinai Hospital.

After City College, Salk enrolled in New York University to study medicine. According to Oshinsky, NYU based its modest reputation on famous alumni, such as Walter Reed, who helped conquer yellow fever. Tuition was "comparatively low, better still, it did not discriminate against Jews, ... while most of the surrounding medical schools--Cornell, Columbia, University of Pennsylvania, and Yale--had rigid quotas in place." Yale, for example, accepted 76 applicants, in 1935, out of a pool of 501. Although 200 of the applicants were Jewish, only five got in. During his years at New York University Medical School, Salk worked as a laboratory technician during the school year and as a camp counselor in the summer.  During Salk's medical studies, he stood out from his peers, according to Bookchin, "not just because of his continued academic prowess--he was Alpha Omega Alpha, the Phi Beta Kappa Society of medical education--but because he had decided he did not want to practice medicine." Instead, he became absorbed in research, even taking a year off to study biochemistry. He later focused more of his studies on bacteriology which had replaced medicine as his primary interest. He said his desire was to help humankind in general rather than single patients. "It was the laboratory work, in particular, that gave new direction to his life."  According to Salk: "My intention was to go to medical school, and then become a medical scientist. I did not intend to practice medicine, although in medical school, and in my internship, I did all the things that were necessary to qualify me in that regard. I had opportunities along the way to drop the idea of medicine and go into science. At one point at the end of my first year of medical school, I received an opportunity to spend a year in research and teaching in biochemistry, which I did. And at the end of that year, I was told that I could, if I wished, switch and get a Ph.D. in biochemistry, but my preference was to stay with medicine. And, I believe that this is all linked to my original ambition, or desire, which was to be of some help to humankind, so to speak, in a larger sense than just on a one-to-one basis."  Concerning his last year of medical school Salk says: "I had an opportunity to spend time in elective periods in my last year in medical school, in a laboratory that was involved in studies on influenza. The influenza virus had just been discovered about a few years before that. And, I saw the opportunity at that time to test the question as to whether we could destroy the virus infectivity and still immunize. And so, by carefully designed experiments, we found it was possible to do so."

Why did he decide to practice medicine?

OUT:
my preference was to stay with medicine.